Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial.

RATIONALE Corticosteroids are the antiinflammatory treatment of choice in asthma. Treatment guidelines are mainly symptom-driven but symptoms are not closely related to airway inflammation. The fraction of nitric oxide in exhaled air (FENO) is a marker of airway inflammation in asthma. OBJECTIVE We evaluated whether titrating steroids on FENO improved asthma management in children. METHODS Eighty-five children with atopic asthma, using inhaled steroids, were allocated to a FENO group (n=39) in which treatment decisions were made on both FENO and symptoms, or to a symptom group (n=46) treated on symptoms only. Children were seen every 3 months over a 1-year period. MEASUREMENTS Symptoms were scored during 2 weeks before visits and 4 weeks before the final visit. FeNO was measured at all visits, and airway hyperresponsiveness and FEV1 were measured at the start and end of the study. Primary endpoint was cumulative steroid dose. RESULTS Changes in steroid dose from baseline did not differ between groups. In the FENO group, hyperresponsiveness improved more than in the symptom group (2.5 vs. 1.1 doubling dose, p=0.04). FEV1 in the FENO group improved, and the change in FEV1 was not significantly different between groups. The FENO group had 8 severe exacerbations versus 18 in the symptom group. The change in symptom scores did not differ between groups. FENO increased in the symptom group; the change in FENO from baseline differed between groups (p=0.02). CONCLUSION In children with asthma, 1 year of steroid titration on FENO did not result in higher steroid doses and did improve airway hyperresponsiveness and inflammation.

[1]  H. Bisgaard,et al.  Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. , 2005, The Journal of allergy and clinical immunology.

[2]  J. Cowan,et al.  Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. , 2005, The New England journal of medicine.

[3]  N. Wilson,et al.  Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. , 2005, American journal of respiratory and critical care medicine.

[4]  W. Hop,et al.  Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission , 2005, Thorax.

[5]  G. Roberts,et al.  Longitudinal study of grass pollen exposure, symptoms, and exhaled nitric oxide in childhood seasonal allergic asthma , 2004, Thorax.

[6]  N. Kissoon,et al.  Exhaled nitric oxide reflects asthma severity and asthma control , 2004, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[7]  P. Gibson,et al.  High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children. , 2003, The Cochrane database of systematic reviews.

[8]  C. Sorkness,et al.  Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. , 2003, The Journal of allergy and clinical immunology.

[9]  Phil A. Silva,et al.  A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. , 2003, The New England journal of medicine.

[10]  B. Beghé,et al.  Airway inflammation in childhood asthma. , 2003, American journal of respiratory and critical care medicine.

[11]  L. Fregonese,et al.  Correlations between exhaled nitric oxide levels, blood eosinophilia, and airway obstruction reversibility in childhood asthma are detectable only in atopic individuals , 2003, Pediatric pulmonology.

[12]  L. Fregonese,et al.  Steroid-Naive Adolescents with Mild Intermittent Allergic Asthma Have Airway Hyperresponsiveness and Elevated Exhaled Nitric Oxide Levels , 2003, The Journal of asthma : official journal of the Association for the Care of Asthma.

[13]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[14]  N. Kissoon,et al.  Measurement of exhaled nitric oxide in children, 2001 , 2002, European Respiratory Journal.

[15]  F. Rasmussen,et al.  Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood. , 2002, American journal of respiratory and critical care medicine.

[16]  R. Djukanović.  Airway inflammation in asthma and its consequences: implications for treatment in children and adults. , 2002, The Journal of allergy and clinical immunology.

[17]  D. Johns,et al.  Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma , 2002, Thorax.

[18]  M. Jünger,et al.  Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. , 2002, The Journal of allergy and clinical immunology.

[19]  M. Ennis,et al.  Outgrown asthma does not mean no airways inflammation , 2002, European Respiratory Journal.

[20]  M. Griese,et al.  Changes of exhaled nitric oxide during steroid treatment of childhood asthma , 1999, European Respiratory Journal.

[21]  H. Hoogsteden,et al.  Airway inflammation is present during clinical remission of atopic asthma. , 2001, American journal of respiratory and critical care medicine.

[22]  I. Adcock,et al.  Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. , 2001, American journal of respiratory and critical care medicine.

[23]  P. Barnes,et al.  Does exhaled nitric oxide reflect asthma control? Yes, it does! , 2001, American journal of respiratory and critical care medicine.

[24]  Y. Tsai,et al.  A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma. , 2001, The Journal of pediatrics.

[25]  P. Barnes,et al.  Exhaled markers of pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[26]  P. V. Grunsven.  The magnitude of fear of adverse effects as a reason for nonparticipation in drug treatment: a short review. , 2001 .

[27]  F. Hargreave,et al.  A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. , 2000, The Journal of allergy and clinical immunology.

[28]  B. Gaston,et al.  Airway nitrogen oxide measurements in asthma and other pediatric respiratory diseases. , 2000, The Journal of pediatrics.

[29]  A. Woolcock,et al.  Lung function growth and its relation to airway hyperresponsiveness and recent wheeze. Results from a longitudinal population study. , 2000, American journal of respiratory and critical care medicine.

[30]  M. Bala,et al.  Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. , 2000, Chest.

[31]  H. Hoogsteden,et al.  Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness. , 2000, American journal of respiratory and critical care medicine.

[32]  D. Postma,et al.  Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study. , 1999, American journal of respiratory and critical care medicine.

[33]  G. Piacentini,et al.  Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children , 1999 .

[34]  J. Vandenbroucke,et al.  Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. , 1999, American journal of respiratory and critical care medicine.

[35]  B. Gaston,et al.  Expired nitric oxide as a marker for childhood asthma. , 1997, The Journal of pediatrics.

[36]  R. Roorda,et al.  One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group. , 1997, American journal of respiratory and critical care medicine.

[37]  D. Yates,et al.  Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. , 1996, American journal of respiratory and critical care medicine.

[38]  B. Rosner,et al.  Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1. , 1995, American journal of respiratory and critical care medicine.

[39]  E. Weitzberg,et al.  Increased amount of nitric oxide in exhaled air of asthmatics. , 1993, The European respiratory journal.

[40]  Phil A. Silva,et al.  The effects of airway hyperresponsiveness, wheezing, and atopy on longitudinal pulmonary function in children: A 6‐year follow‐up study , 1992, Pediatric pulmonology.